Autoantibodies against galectin-8: Their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation

dc.date.accessioned2020-03-11T20:32:21Z
dc.date.accessioned2022-10-18T22:53:39Z
dc.date.available2020-03-11T20:32:21Z
dc.date.available2022-10-18T22:53:39Z
dc.date.created2020-03-11T20:32:21Z
dc.date.issued2009
dc.identifierhttp://hdl.handle.net/10533/239692
dc.identifier13980001
dc.identifierWOS:000266265000009
dc.identifierno scielo
dc.identifiereid=2-s2.0-65549122918
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4471031
dc.description.abstractThe role of autoantibodies in the pathogenesis of systemic lupus erythematosus (SLE) has not been completely defined. From more than a hundred autoantibodies described in SLE, relatively few have been associated with clinical manifestations. The glycan-bi
dc.languageeng
dc.relationhttps://doi.org/10.1177/0961203308099973
dc.relation10.1177/0961203308099973
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titleAutoantibodies against galectin-8: Their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation
dc.typeArticulo


Este ítem pertenece a la siguiente institución